Peptide record

TPDB12057

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
44 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB12057
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb
standard
No
A 44-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
VTCDLLSAEAKGVKVNHAACAAHCLLKRKRGGYCNKRRICVCRN
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C201H347N71O55S6
QMFPW
AC
4830.77
9.93
12
2
16
+8
2.07
-0.173
84.32
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
1865
0.39
12
Residue Composition
number
6
A
5
R
3
N
1
D
6
C
1
E
0
Q
3
G
2
H
1
I
4
L
5
K
0
M
0
F
0
P
1
S
1
T
0
W
1
Y
4
V
Amino Acid Distribution
A: 6 R: 5 N: 3 D: 1 C: 6 E: 1 Q: 0 G: 3 H: 2 I: 1 L: 4 K: 5 M: 0 F: 0 P: 0 S: 1 T: 1 W: 0 Y: 1 V: 4
Chemical Descriptors
44 reviewed residue count
C201H347N71O55S6 sequence-only estimate (linear, free termini)
4830.77 sequence-only estimate (linear, free termini)
9.93 sequence-only estimate (linear, free termini)
+8 sequence-only estimate (linear, free termini)
2.07 sequence-only estimate (linear, free termini)
-0.173 sequence-only estimate (linear, free termini)
Evidence Records 18 records
Evidence 1 Activity

Activity

MIC
Antibacterial
13.2 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against E-coli (MIC >75 ug/ml), S. aureus (MIC 13.2 ug/ml), B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and
Evidence 2 Activity

Activity

MIC
Antibacterial
6 µM

Target

B. subtilis

Source & Reference

dbAMP DRAMP

Other

active against E-coli (MIC >75 ug/ml), S. aureus (MIC 13.2 ug/ml), B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and K.pneumoniae (MIC >200 u
Evidence 3 Activity

Activity

MIC
Antibacterial
4.6 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

ctive against E-coli (MIC >75 ug/ml), S. aureus (MIC 13.2 ug/ml), B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and K.pneumoniae (MIC >200 ug/ml). In vitro toxicity: non
Evidence 4 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP DRAMP

Other

ug/ml), S. aureus (MIC 13.2 ug/ml), B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and K.pneumoniae (MIC >200 ug/ml). In vitro toxicity: non-hemo.lytic till 200 ug/ml.
Evidence 5 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

K.pneumoniae

Source & Reference

dbAMP DRAMP

Other

, B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and K.pneumoniae (MIC >200 ug/ml). In vitro toxicity: non-hemo.lytic till 200 ug/ml.
Evidence 6 Activity

Activity

MIC
Antifungal
13.2 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
active against E-coli (MIC >75 ug/ml), S. aureus (MIC 13.2 ug/ml), B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and
Evidence 7 Activity

Activity

MIC
Antifungal
6 µM

Target

B. subtilis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

active against E-coli (MIC >75 ug/ml), S. aureus (MIC 13.2 ug/ml), B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and K.pneumoniae (MIC >200 u
Evidence 8 Activity

Activity

MIC
Antifungal
4.6 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ctive against E-coli (MIC >75 ug/ml), S. aureus (MIC 13.2 ug/ml), B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and K.pneumoniae (MIC >200 ug/ml). In vitro toxicity: non
Evidence 9 Activity

Activity

MIC
Antifungal
>200 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ug/ml), S. aureus (MIC 13.2 ug/ml), B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and K.pneumoniae (MIC >200 ug/ml). In vitro toxicity: non-hemo.lytic till 200 ug/ml.
Evidence 10 Activity

Activity

MIC
Antifungal
>200 µg/mL

Target

K.pneumoniae

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

, B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and K.pneumoniae (MIC >200 ug/ml). In vitro toxicity: non-hemo.lytic till 200 ug/ml.
Evidence 11 Activity

Activity

MIC
Antiparasitic
13.2 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
active against E-coli (MIC >75 ug/ml), S. aureus (MIC 13.2 ug/ml), B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and
Evidence 12 Activity

Activity

MIC
Antiparasitic
6 µM

Target

B. subtilis

Source & Reference

DRAMP

Other

active against E-coli (MIC >75 ug/ml), S. aureus (MIC 13.2 ug/ml), B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and K.pneumoniae (MIC >200 u
Evidence 13 Activity

Activity

MIC
Antiparasitic
4.6 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

ctive against E-coli (MIC >75 ug/ml), S. aureus (MIC 13.2 ug/ml), B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and K.pneumoniae (MIC >200 ug/ml). In vitro toxicity: non
Evidence 14 Activity

Activity

MIC
Antiparasitic
>200 µg/mL

Target

P.aeruginosa

Source & Reference

DRAMP

Other

ug/ml), S. aureus (MIC 13.2 ug/ml), B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and K.pneumoniae (MIC >200 ug/ml). In vitro toxicity: non-hemo.lytic till 200 ug/ml.
Evidence 15 Activity

Activity

MIC
Antiparasitic
>200 µg/mL

Target

K.pneumoniae

Source & Reference

DRAMP

Other

, B. subtilis (MIC 6 uM), C. albicans (MIC 4.6 ug/ml), P.aeruginosa (MIC >200 ug/ml), and K.pneumoniae (MIC >200 ug/ml). In vitro toxicity: non-hemo.lytic till 200 ug/ml.
Evidence 16 Activity

Activity

0% Hemolysis
Toxicity
200 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 200 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Identification and screening of potent antimicrobial peptides in arthropod genomes. | Peptides | 2018
Evidence 17 Activity

Activity

Toxicity
Hemolytic Cytotoxic
- | NA | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A Defensin from the Model Beetle Tribolium castaneum Acts Synergistically with Telavancin and Daptomycin against Multidrug Resistant Staphylococcus aureus. | PLoS One | 2015
Evidence 18 Activity

Activity

% Hemolysis
Toxicity
0 %
Hemolytic
Hemolytic_activity: [Ref.29501691] 0% haemolysis at 10 µg/ml, 0% haemolysis at 25 µg/ml, 0% haemolysis at 50 µg/ml, 0% haemolysis at 100 µg/ml, 0% haemolysis at 200 µg/ml against sheep red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Peptides. 2018 May 103:26-30. doi: 10.1016/j.peptides.2018.01.017.